SpendMend Pharmacy leverages the expertise of Turnkey Pharmacy Solutions to deliver Optimization solutions to pharmacies across the country. Our team of over 28 pharmacy experts works with clients to customize a sequence of solutions to help reduce costs and optimize savings.
Bottom Line Impact
SpendMend Pharmacy consistently reduces annual drug spend for our clients by an average of 3%. The
percentage of savings varies based on annual spend volume, but wherever your CE lands on the chart below,
the dollars are significant.
Why CE’s Choose SpendMend Pharmacy for 340B Optimization
Drive an average of 3% savings on your annual drug spend
Work with the industry leader in spend optimization
Gain insight on the best practices of leading pharmacies
Benefit from a combined 250 years of pharmacy experience
SpendMend Pharmacy Spend Optimization Program
Price Parity
Review wholesale spend for all purchasing accounts within a system to ensure consistent best available contract pricing.
Historical Price Spikes
Analytics and insights into price spikes to reverse unnecessary costs and prevent unnecessary over-spending.
NDC Optimization
Analytics and insights for lower cost NDC alternatives of the same drug.
Benchmarking
Analysis of GPO rates and utilization percentages to drive better COGS and ensure optimal compliance with GPO contracts.
Rebate/Contract Review
Biosimilars
Price Fluctuations
Tools to anticipate future price fluctuations to optimize pharmacy costs.
Unit Dose (UD) to Pre-Packaging Opportunities
Review commercial UD spend and recommend savings opportunities where appropriate. (Bi-directional analysis).
Sales & Use Tax
Evaluation and analysis to determine if pharmacy is overpaying sales and use taxes.
Consignment Opportunity
Evaluation and analysis of consignment fees to help hospitals refine their consignment strategy.
Pharmacy Leader – Nationwide, nonprofit health system, $330M in annual drug spend.
DATA SHEET
Pharmacy Spend Optimization (PSO) Overview
Getting Started
SpendMend By The Numbers
CLIENTS SERVED SINCE 2012
AUDITS COMPLETED
%